Fig. 4From: Based on whole-exome sequencing to explore the rule of Herceptin and TKI resistance in breast cancer patientsThe confirmatory comparison of HI and YI. AÂ Type of base mutation of HI and YI. BÂ MSI status of YI and HI; CÂ Proportion of mutations of YI and HIBack to article page